Smallcaps Investment Research

It’s very unfortunate Dr. Hasegawa wasn’t able to attend the Annual Conference of the Japanese Society For Vaccinology held in Sapporo, Japan on September 27, 2009. Although an abstract was published on the Hemispherx website, we feel as if the investment community only glanced over the presentation. To help us clarify the abstract, we had a conference call this week […]

We also received positive news from our biotech stock Hemispherx Biopharma (HEB – $2.05). The Company will spend up to $4.4 million for engineering studies, capital improvements, system upgrades, and introduction of building management systems to enhance production for Alferon N and its two experimental therapeutics Alferon LDO and Ampligen. These investments will bring the capacity of Hemispherx’ manufacturing site […]

Furthermore Boots & Coots (WEL – $1.68) announced it acquired the external abrasive jet cutting systems from Halliburton Company. The abrasive jet cutting system was developed by Halliburton in 1991 to assist firefighting crews in Kuwait battle more than seven hundred fires left after the Iraq invasion. The external abrasive jet cutter is designed to be easily positioned on a […]

Hemispherx Biopharma (HEB – $2.03) announced on Wednesday it cancelled its adjourned stockholders’ meeting. The reason was very simple, the Company obtained insufficient votes to pass proposal no. 3. With this proposal being the sole purpose of the adjourned stockholders’ meeting, there was no need to hold the meeting. In proposal 3, shareholders were asked if HEB could increase the […]

Many thanks to everybody who responded by e-mail or on our blog to last week’s appeal: “Do you have an idea why Orsus Xelent (ORS – $0.72) is trading at such a low P/E?”. Most answers were unanimous and something like: management (CEO, CFO and several members of the board) and the Company’s auditor has changed during the last few […]

Once again Orsus Xelent (ORS – $0.75) reported excellent results. The Chinese designer and manufacturer of mobile phones for the Asian market announced revenues in the second quarter ended June 30, 2009 of $23,332,000, compared with $28,894,000 in the second quarter of 2008, a decline of 19.25%. However, net income increased 53.19% to $2,307,000 or $0.08 per share, up from […]

While we’re still waiting for the FDA to make a decision regarding Hemisperx Biopharma’s (HEB – $2.00) NDA for Ampligen to treat Chronic Fatigue Syndrome (CFS), mutual funds have been big buyers of HEB’s shares. In the second quarter, ending June 30, 2009, mutual funds have added 8.36 million shares of Hemispherx, or 6.6% of total shares outstanding, to their […]

At a time of year when the number of press releases is relatively low, one Company, that we have been following for some time, stood out this week with two announcements: Clearfield Inc. (CLFD – $1.77) . Clearfield, which manufactures and sells fiber distribution systems, optical components, outside plant cabinets, and fiber and copper cable assemblies for the telecommunications industry, […]